These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 26874306)

  • 101. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
    Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
    Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Tetradentate polyamines as efficient metallodrugs for Chagas disease treatment in murine model.
    Olmo F; Costas M; Marín C; Rosales MJ; Martín-Escolano R; Cussó O; Gutierrez-Sánchez R; Ribas X; Sánchez-Moreno M
    J Chemother; 2017 Apr; 29(2):83-93. PubMed ID: 27251893
    [TBL] [Abstract][Full Text] [Related]  

  • 103. In vitro and in vivo trypanosomicidal activity of pyrazole-containing macrocyclic and macrobicyclic polyamines: their action on acute and chronic phases of Chagas disease.
    Sánchez-Moreno M; Marín C; Navarro P; Lamarque L; García-España E; Miranda C; Huertas O; Olmo F; Gómez-Contreras F; Pitarch J; Arrebola F
    J Med Chem; 2012 May; 55(9):4231-43. PubMed ID: 22443115
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Prospects of an alternative treatment against Trypanosoma cruzi based on abietic acid derivatives show promising results in Balb/c mouse model.
    Olmo F; Guardia JJ; Marin C; Messouri I; Rosales MJ; Urbanová K; Chayboun I; Chahboun R; Alvarez-Manzaneda EJ; Sánchez-Moreno M
    Eur J Med Chem; 2015 Jan; 89():683-90. PubMed ID: 25462275
    [TBL] [Abstract][Full Text] [Related]  

  • 105. In vitro and in vivo identification of tetradentated polyamine complexes as highly efficient metallodrugs against Trypanosoma cruzi.
    Olmo F; Cussó O; Marín C; Rosales MJ; Urbanová K; Krauth-Siegel RL; Costas M; Ribas X; Sánchez-Moreno M
    Exp Parasitol; 2016 May; 164():20-30. PubMed ID: 26874306
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Trypanothione Reductase and Superoxide Dismutase as Current Drug Targets for Trypanosoma cruzi: An Overview of Compounds with Activity against Chagas Disease.
    Beltran-Hortelano I; Perez-Silanes S; Galiano S
    Curr Med Chem; 2017 May; 24(11):1066-1138. PubMed ID: 28025938
    [TBL] [Abstract][Full Text] [Related]  

  • 107. [The chemotherapy of Chagas disease].
    Stoppani AO
    Medicina (B Aires); 1999; 59 Suppl 2():147-65. PubMed ID: 10668258
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Indazoles: a new top seed structure in the search of efficient drugs against Trypanosoma cruzi.
    Aguilera-Venegas B; Olea-Azar C; Arán VJ; Speisky H
    Future Med Chem; 2013 Oct; 5(15):1843-59. PubMed ID: 24144415
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Trypanothione reductase inhibitors: Overview of the action of thioridazine in different stages of Chagas disease.
    Lo Presti MS; Bazán PC; Strauss M; Báez AL; Rivarola HW; Paglini-Oliva PA
    Acta Trop; 2015 May; 145():79-87. PubMed ID: 25733492
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Nonsteroidal Anti-Inflammatory Drugs and Experimental Chagas Disease: An Unsolved Question.
    Nicolau ST; Tres DP; Ayala TS; Menolli RA
    Parasite Immunol; 2024 Jul; 46(7):e13057. PubMed ID: 39008292
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Polyamines and Related Nitrogen Compounds in the Chemotherapy of Neglected Diseases Caused by Kinetoplastids.
    Bisceglia JA; Mollo MC; Gruber N; Orelli LR
    Curr Top Med Chem; 2018; 18(5):321-368. PubMed ID: 29701142
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Molecular targets for Chagas disease: validation, challenges and lead compounds for widely exploited targets.
    Laureano de Souza M; Lapierre TJWJD; Vitor de Lima Marques G; Ferraz WR; Penteado AB; Henrique Goulart Trossini G; Murta SMF; de Oliveira RB; de Oliveira Rezende C; Ferreira RS
    Expert Opin Ther Targets; 2023; 27(10):911-925. PubMed ID: 37772733
    [TBL] [Abstract][Full Text] [Related]  

  • 113.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.